Ugonma N. Chukwueke

Neurology
450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Germline determinants of risk and molecular subtype in young-onset lung cancer.

Germline determinants of risk and molecular subtype in young-onset lung cancer.

Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Journal: Neuro-oncology advances
Published: October 24, 2025

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Journal: Neuro-oncology
Published: August 04, 2025

Clinical Problem Solving: A 68-Year-Old Woman With Acute Apraxic Agraphia, Constructional Apraxia, and Finger Agnosia.

Clinical Problem Solving: A 68-Year-Old Woman With Acute Apraxic Agraphia, Constructional Apraxia, and Finger Agnosia.

Journal: The Neurohospitalist
Published: July 05, 2025

Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.

Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.

Journal: Science advances
Published: June 04, 2025

Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.

Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.

Journal: Neuro-oncology
Published: May 29, 2025

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

Journal: Blood advances
Published: May 13, 2025

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.

Journal: Neuro-oncology
Published: May 03, 2025

Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.

Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.

Journal: Neuro-oncology practice
Published: February 07, 2025

Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.

Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.

Journal: Neuro-oncology advances
Published: February 06, 2025

Enhancing neuro-oncology care through equity-driven applications of artificial intelligence.

Enhancing neuro-oncology care through equity-driven applications of artificial intelligence.

Journal: Neuro-oncology
Published: August 19, 2024
Showing 1-12 of 57

Last Updated: 09/26/2026